Partnership to Advance Joint Feline Kidney Health Research, Including Studies Involving Tigers

Greycoat Research has signed an exclusive supply and distribution partnership with Indian animal healthcare company Goodman Vetcare, marking the company’s entry into the South Asian market.

The agreement represents Greycoat Research’s second overseas exclusive partnership following its contract in Türkiye.

Beyond introducing its products to the Indian market, Greycoat Research plans to establish India as a strategic base for global veterinary research and development.

Founded in 1984, Goodman Vetcare is a leading Indian animal healthcare company with an animal hospital distribution network and the veterinary professional platform Animeal.in.

The company recorded approximately INR 800 million, equivalent to around KRW 12.1 billion, in sales during the 2025 fiscal year.

Through the partnership, Greycoat Research and Goodman Vetcare will expand their cooperation beyond product distribution to include veterinary academic education and long-term joint clinical research.

One of the key areas of collaboration will be kidney health research involving not only domestic cats but also large felines such as tigers.

By combining Goodman Vetcare’s network of local laboratories and wildlife institutions with Greycoat Research’s expertise in chronic kidney disease care, the two companies plan to conduct phased joint studies.

The research will focus on establishing kidney health protocols for companion cats and large felines living in wildlife parks and zoos.

As part of the partnership, Greycoat Research executives and employees visited 13 veterinary institutions across four major regions in India: Mumbai, Gujarat, Delhi, and Bengaluru.

During the visit, the team participated in in-depth academic exchanges with local veterinary professionals and institutions.

At the Dogs & Cats Clinic, operated by the president of the Pet Practitioners Association of Mumbai, and CGS Hospital in Delhi, Greycoat Research shared its feline kidney disease management systems and discussed the potential application of these approaches to large felines.

“Through in-depth exchanges with India’s veterinary community, we have established a strong foundation for local research and distribution,” said Yun Jeong eun, CEO of Greycoat Research.

“By utilizing local infrastructure, we aim to generate annual demand of approximately 40,000 to 50,000 units over the mid to long term. We will also strengthen data-driven global clinical collaboration to expand our presence in overseas markets.”

The partnership represents another important step in Greycoat Research’s efforts to build an international research and distribution network centered on feline kidney health.

By combining India’s veterinary infrastructure with its accumulated expertise in CKD care, Greycoat Research plans to continue developing data-driven healthcare solutions and expanding international clinical collaboration.

For partnership, distribution, research, or veterinary collaboration inquiries, please contact:
sales@greycoatresearch.com

Read the original article:
Greycoat Research Signs Exclusive Deal with India’s Goodman Vetcare for Cat Kidney Product

[Disclaimer]
Greycoat Research develops nutritional supplements and care programs designed to support feline well-being. Its products are not intended to diagnose, treat, cure, or prevent any disease. Pet owners should consult a licensed veterinarian for medical advice.